跳至主要内容
临床试验/ACTRN12620000739910
ACTRN12620000739910招募中未知

An evaluation of the clinical utility and acceptability of maternally-administered foetal heart rate monitoring using a remote medical device The HeraBEAT Trial.

Paul Porter0 个研究点目标入组 120 人开始时间: 2020年7月16日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Diagnosis
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
Female

入选标准

  • Any expectant mother over 18 years of age with a singleton pregnancy who is attending the Joondalup Health Campus antenatal clinic from 12 weeks gestation. Participants will be recruited as a convenience sample after eligibility is assessed.

排除标准

  • 1.Twin, triplets or other multi-foetal pregnancies
  • 2.Non-English readers
  • 3.Informed consent not obtained
  • 4.No access to an appropriate smartphone or internet connectivity
  • 5.Pacemaker or other implantable electronic devices
  • 6.Skin condition or rash in the abdominal area
  • 7.Anterior placenta
  • 8.In active labour

研究者

发起方
Paul Porter

相似试验

An evaluation of the reliability and ease of use of... | 临床试验